Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Markets
/
Stocks
/
nasdaq-naya
/
NAYA Biosciences Inc
NAYA
2.200
USD
+0.210
+10.34%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
8.59M
Market Cap
Loss
P/E TTM
NAYA Biosciences Inc
2.200
+0.210
+10.34%
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024Q3
Total equity
Cash, cash equivalents and short-term investments
--
471.59K
- Cash and cash equivalents
--
471.59K
Receivables
--
257.05K
-Accounts and notes receivable
--
257.05K
Inventory
--
241.54K
Prepaid expenses
--
987.30K
Total current assets
--
1.96M
Non-current assets
Net Fixed Assets
--
2.76M
-Fixed Assets
--
3.07M
-Accumulated depreciation
--
308.26K
Goodwill and other intangible assets
--
9.36M
Total non-current assets
--
15.06M
Total assets
--
17.02M
Liabilities
Current liabilities
-Other payables
--
2.85M
Accrued expenses
--
640.04K
Short-term debt and lease liabilities
--
1.72M
-Short-term debt
--
880.00K
Deferred liabilities
--
562.40K
Other current liabilities
--
3.41M
Total current liabilities
--
8.66M
Non-current liabilities
Long-term debt and lease liabilities
--
3.39M
-Long-term debt
--
1.13M
-Long-term lease liabilities
--
2.25M
Other non-current liabilities
--
5.00M
Total non-current liabilities
--
8.39M
Total liabilities
--
17.04M
Shareholders' equity
Common equity
--
55.87M
Retained earnings
--
-63.54M
Capital reserves
--
55.87M
Total equity
--
-23.32K
Currency unit
USD
Audit opinions
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up